Fact Sheets & Backgrounders Key Facts to Know Before Novo Nordisk’s CEO Appears at the Senate HELP Committee September 17, 2024
Letters, Testimony & Filings Testimony Before the FDA’s Antimicrobial Drugs Advisory Committee Meeting about Sulopenem Etzadroxil/Probenecid for Uncomplicated Urinary Tract Infection September 9, 2024
Letters, Testimony & Filings Stakeholder comment to Reagan-Udall/FDA meeting regarding the treatment for PTSD September 6, 2024
Outrage of the Month: a Senior FDA Official Regulated Medical Devices While His Wife’s Law Firm Represented Their Manufacturers September 1, 2024
Letters, Testimony & Filings Letter Urging Gavi, UNICEF to Negotiate Fair Price of Mpox Vaccines August 27, 2024